The $60 Million Dividend: How Home-Based Care is Healing Medicare

NEW YORK, NY – July 22, 2026

In the relentless battle against rising healthcare costs, a figure like $60 million in savings for Medicare is more than a rounding error—it's a signal. Empassion Health, a managed-care provider specializing in serious illness, announced today it had generated nearly that amount in net savings for the federal program in 2024. The achievement wasn't the result of rationing care or a miraculous new drug. Instead, it stemmed from a deliberate, coordinated effort to provide palliative and hospice care to the nation's sickest patients where they most want to be: at home.

This isn't just a financial story. It's a story about aligning incentives with humanity. For years, the healthcare system has implicitly rewarded high-volume, high-cost interventions, often leading to repeated, distressing, and expensive hospitalizations for those in the final chapters of their lives. Empassion's results, validated through a rigorous federal program, suggest a viable, scalable alternative where better care is also, remarkably, cheaper care.

A Model for a High-Stakes Problem

The savings were generated within the High Needs Population Track of the Centers for Medicare & Medicaid Services' (CMS) ACO REACH Model. This program isn't for the average patient; it’s specifically designed to serve the most medically complex and frail adults—a group representing just 5% of Medicare beneficiaries but accounting for a staggering 25% of the program's total spending. This is the epicenter of Medicare's cost crisis.

Empassion’s success is a standout data point within an already successful federal initiative. For performance year 2024, the ACO REACH model as a whole generated $988.3 million in net savings for the government. Notably, the High Needs ACOs, like Empassion, achieved an average net savings rate of 14.0%, far outpacing other tracks in the program. This demonstrates that focusing resources on the most vulnerable populations can yield the most significant returns, both financially and clinically.

"These results reinforce something we've believed from the beginning — that the highest quality care and lower costs are not competing priorities," said Robin Heffernan, co-founder and CEO of Empassion. Her statement cuts to the core of the value-based care proposition: when the system is incentivized to produce good outcomes rather than just perform procedures, efficiency and patient satisfaction follow. By preventing avoidable hospital stays and providing comprehensive support, the model reduces the strain on the most expensive parts of the healthcare system.

Deconstructing the 'Secret Sauce': Tech, Touch, and Trust

So how does Empassion's model work? It’s a synthesis of modern technology and old-fashioned human touch. The company acts as a specialized managed-care layer, partnering with health plans and other risk-bearing entities. Using proprietary algorithms, it identifies patients with serious, advanced illnesses who are at high risk for hospitalization and could benefit from an extra layer of support.

Once a patient is enrolled, Empassion mobilizes its national network of vetted, community-based palliative and hospice providers. This is a crucial distinction. Palliative care, often misunderstood as solely end-of-life care, is specialized medical support focused on providing relief from the symptoms and stress of a serious illness. It can be provided at any stage and alongside curative treatment. Empassion’s model integrates this with a seamless transition to hospice care if and when a patient's goals shift toward comfort in their final months.

Care is delivered primarily through in-home visits and telehealth consultations by local teams that include nurse practitioners, registered nurses, social workers, and chaplains. They manage physical and emotional symptoms, conduct home safety evaluations, reconcile medications, and, critically, facilitate advance care planning. These are the difficult but essential conversations about a patient’s goals and wishes, ensuring their care aligns with what matters most to them. This comprehensive support structure has reportedly led to a 47% reduction in hospitalizations and a 35% lower total cost of care, according to the company's internal studies.

The Human Bottom Line: More Good Days, Less Hospital Chaos

Beyond the impressive financial metrics lies the tangible impact on patients and their families. The company’s mission is to help adults with serious illness have "more good days," a simple but profound goal. For families navigating the complexities of advanced dementia, heart failure, or cancer, the constant cycle of emergency room visits and hospital admissions is exhausting and traumatic. A coordinated, home-based model offers stability and support.

With a reported 98% patient satisfaction rate, the approach appears to be resonating. Testimonials from family members speak to the relief of having a dedicated team managing their loved one's care. One family member noted the service was a lifeline, stating, "They have taken wonderful care of my Aunt and I would recommend them to others." This qualitative feedback aligns with the quantitative data. Fewer hospitalizations mean more time spent in familiar surroundings, surrounded by loved ones—an outcome whose value cannot be measured in dollars.

This model also provides critical support for caregivers, who bear an immense physical and emotional burden. By providing education, resources, and a professional team to lean on, programs like this help sustain the informal care network that is the backbone of our long-term care system.

A Blueprint for the Future of Medicare?

The timing of these results is significant. While the ACO REACH model is set to conclude at the end of 2026, CMS is immediately replacing it with ACO LEAD, a new 10-year model, signaling a long-term federal commitment to this value-based approach. Empassion's success provides a powerful case study for how to structure care for the highest-need populations going forward.

"Over the past four years, Empassion has consistently demonstrated that its coordinated serious illness care model improves patient outcomes while reducing total cost of care," said Chase Knight, the company's chief growth officer. He emphasized that the model's success across different Medicare plans—Original, Medicare Advantage, and Special Needs Plans—proves its adaptability.

The challenge, however, remains significant. The palliative care market, though growing rapidly, still faces hurdles, including widespread misconceptions among both clinicians and the public, which often lead to late referrals. Empassion is tackling this head-on, not only through its care model but also through initiatives like its "Empassion Assured" certification for hospice providers, designed to build trust in a sector that has faced scrutiny.

As the U.S. population ages and the prevalence of chronic disease grows, the need for sustainable, humane care models will only become more acute. The $60 million in savings is the headline, but the real story is the validation of a system that prioritizes coordinated, compassionate care at home, proving it is not only the right thing to do for patients but also the smart thing to do for the healthcare system.